Finance

Lists
Why is 1PFE down 2,32%?
Dive Deeper
1PFE:BIT
Pfizer Inc
24,64 €
-2,32%
(-0,59) 1D
2-окт., 17:35:14 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1PFE...
Open
25,04 €
High
25,08 €
Low
24,60 €
Mkt. cap
161,19 млд
Avg. vol.
6,44 миң
Volume
2,94 миң
52-wk high
25,50 €
52-wk low
20,45 €
No. of employees
75 миң
Open
25,04 €
High
25,08 €
Low
24,60 €
Mkt. cap
161,19 млд
Avg. vol.
6,44 миң
Volume
2,94 миң
52-wk high
25,50 €
52-wk low
20,45 €
No. of employees
75 миң
News stories
From web sources and news partners
Profile
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America. Pfizer develops and produces medication and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis, Prevnar, Paxlovid, Vyndaqel, Comirnaty, and Ibrance. In 2025, 59% of the company's revenues came from the United States, 5% came from China, and 36% came from other countries. The company is ranked fifth on the list of largest biomedical companies by revenue. It is ranked the 69th on the Fortune 500 and 73rd on the Forbes Global 2000. Wikipedia
About Pfizer Inc
CEOAlbert Bourla
Employees75 миң
Founded1849
HeadquartersНью-Йорк, Нью Йорк, Америка Кошмо Штаттары
SectorPharmaceutical industry
Websitepfizer.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
16,65 млд
17,56 млд
14,45 млд
15,03 млд
Cost of goods sold
3,98 млд
5,06 млд
3,41 млд
3,66 млд
Cost of revenue
3,98 млд
5,06 млд
3,41 млд
3,66 млд
Research and development expenses
2,49 млд
3,32 млд
2,45 млд
2,75 млд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,08 млд
3,74 млд
2,84 млд
3,26 млд
Operating expense
6,80 млд
8,29 млд
6,48 млд
7,19 млд
Total operating expenses
10,78 млд
13,35 млд
9,88 млд
10,84 млд
Operating income
5,88 млд
4,20 млд
4,57 млд
4,19 млд
Other non operating income
181,00 млн
1,35 млд
36,00 млн
515,00 млн
EBT including unusual items
3,33 млд
-1,64 млд
3,17 млд
-653,00 млн
EBT excluding unusual items
5,54 млд
5,09 млд
4,13 млд
4,25 млд
Income tax expense
-216,00 млн
-2,00 млн
461,00 млн
-407,00 млн
Effective tax rate
-6,48%
0,12%
14,55%
62,33%
Other operating expenses
-
-
-
-
Net income
3,54 млд
-1,65 млд
2,69 млд
-248,00 млн
Net profit margin
21,26%
-9,39%
18,59%
-1,65%
Earnings per share
0,87
0,66
0,75
0,77
Interest and investment income
138,00 млн
247,00 млн
197,00 млн
211,00 млн
Interest expense
-652,00 млн
-711,00 млн
-668,00 млн
-667,00 млн
Net interest expenses
-514,00 млн
-464,00 млн
-471,00 млн
-456,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
7,53 млд
5,86 млд
6,18 млд
5,80 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору